Paper8099725
Collagen-induced morphogenesis and expression of the alpha 2-integrin subunit is inhibited in c-erbB2-transfected human mammary epithelial cells.
D'Souza B and 3 others. Oncogene, 1993. Cited by 79 papers, by iCite.
Cite this record
ConductScience Library. Collagen-induced morphogenesis and expression of the alpha 2-integrin subunit is inhibited in c-erbB2-transfected human mammary epithelial cells. Papers, record 8099725. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8099725
- Cell line
- MTSV1-74 papers
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Collagen-induced morphogenesis and expression of the alpha 2-integrin subunit is inhibited in c-erbB2-transfected human mammary epithelial cells.
- PubMed
Connected records3
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast | Major topic |
| Cell Transformation, Neoplastic | Major topic |
| Collagen | Major topic |
| Integrins | Major topic |
| Proto-Oncogene Proteins | Major topic |
| Proto-Oncogenes | Major topic |
| Cell Line, Transformed | |
| Epithelium | |
| Female | |
| Humans | |
| Morphogenesis | |
| Erb-b2 Receptor Tyrosine Kinases | |
| Transfection |
Source PubMed
Cited by31
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 79 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36358657 | A Multi-Center Clinical Study to Harvest and Characterize Circulating Tumor Cells from Patients with Metastatic Breast Cancer Using the Parsortix® PC1 System. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36358657 | PubMed |
| 27199219 | Trastuzumab-targeted gene delivery to Her2-overexpressing breast cancer cells. | Cancer Gene Ther | 2016 | https://conductscience.org/library/papers/27199219 | PubMed |
| 25915532 | Development and characterisation of a 3D multi-cellular in vitro model of normal human breast: a tool for cancer initiation studies. | Oncotarget | 2015 | https://conductscience.org/library/papers/25915532 | PubMed |
| 24807106 | The effect of chemotherapeutic agents on telomere length maintenance in breast cancer cell lines. | Breast Cancer Res Treat | 2014 | https://conductscience.org/library/papers/24807106 | PubMed |
| 21822945 | Mechanisms by which the extracellular matrix and integrin signaling act to regulate the switch between tumor suppression and tumor promotion. | J Mammary Gland Biol Neoplasia | 2011 | https://conductscience.org/library/papers/21822945 | PubMed |
| 16199884 | Zinc finger transcription factors designed for bispecific coregulation of ErbB2 and ErbB3 receptors: insights into ErbB receptor biology. | Mol Cell Biol | 2005 | https://conductscience.org/library/papers/16199884 | PubMed |
| 16168102 | Differential responses to doxorubicin-induced phosphorylation and activation of Akt in human breast cancer cells. | Breast Cancer Res | 2005 | https://conductscience.org/library/papers/16168102 | PubMed |
| 15509657 | Insulin-like growth factor I controls adhesion strength mediated by alpha5beta1 integrins in motile carcinoma cells. | Mol Biol Cell | 2005 | https://conductscience.org/library/papers/15509657 | PubMed |
| 12181354 | c-erbB2-induced disruption of matrix adhesion and morphogenesis reveals a novel role for protein kinase B as a negative regulator of alpha(2)beta(1) integrin function. | Mol Biol Cell | 2002 | https://conductscience.org/library/papers/12181354 | PubMed |
| 12013529 | The role of c-erbB-2/HER2/neu in breast cancer progression and metastasis. | J Mammary Gland Biol Neoplasia | 2001 | https://conductscience.org/library/papers/12013529 | PubMed |
| 11533657 | ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini. | Nat Cell Biol | 2001 | https://conductscience.org/library/papers/11533657 | PubMed |
| 11030148 | Activation of the alpha2beta1 integrin prevents c-erbB2-induced scattering and apoptosis of human mammary epithelial cells in collagen. | Oncogene | 2000 | https://conductscience.org/library/papers/11030148 | PubMed |
| 10887494 | Cell adhesion molecules in the normal and cancerous mammary gland. | J Mammary Gland Biol Neoplasia | 1996 | https://conductscience.org/library/papers/10887494 | PubMed |
| 10819527 | Altered integrin expression and the malignant phenotype: the contribution of multiple integrated integrin receptors. | J Mammary Gland Biol Neoplasia | 1998 | https://conductscience.org/library/papers/10819527 | PubMed |
| 10698518 | Cofactor competition between the ligand-bound oestrogen receptor and an intron 1 enhancer leads to oestrogen repression of ERBB2 expression in breast cancer. | Oncogene | 2000 | https://conductscience.org/library/papers/10698518 | PubMed |
| 10607920 | Complexity of signal transduction mediated by ErbB2: clues to the potential of receptor-targeted cancer therapy. | Pathol Oncol Res | 1999 | https://conductscience.org/library/papers/10607920 | PubMed |
| 10487850 | Collagen receptor control of epithelial morphogenesis and cell cycle progression. | Am J Pathol | 1999 | https://conductscience.org/library/papers/10487850 | PubMed |
| 9662255 | Effects of retinoic acid and fenretinide on the c-erbB-2 expression, growth and cisplatin sensitivity of breast cancer cells. | Br J Cancer | 1998 | https://conductscience.org/library/papers/9662255 | PubMed |
| 9649145 | VLA2 integrin expression in breast carcinomas evaluated by automated and quantitative immunohistochemistry. | Br J Cancer | 1998 | https://conductscience.org/library/papers/9649145 | PubMed |
| 9182658 | A transfected sialyltransferase that is elevated in breast cancer and localizes to the medial/trans-Golgi apparatus inhibits the development of core-2-based O-glycans. | J Cell Biol | 1997 | https://conductscience.org/library/papers/9182658 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ERBB2 | 2064 | PubTator's text mining | https://conductscience.org/library/genes/2064 | NCBI Gene |
| GPHA2 | 170589 | PubTator's text mining | https://conductscience.org/library/genes/170589 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8099725
GET https://conductscience.org/api/papers/v1/8099725/cited_by?page=2